Iqvia Holdings (IQV) Receivables (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Receivables came in at $5.2 billion in Q2 2026, down 2.14% year-over-year from $5.3 billion in Q2 2025, and little changed quarter-over-quarter from $5.2 billion in Q1 2026.
Analysis
Iqvia Holdings (IQV) Receivables (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Receivables across 15 years of filings, most recently posting $5.2 billion for Q2 2026.
- In Q2 2026, Receivables fell 2.14% year-over-year to $5.2 billion; the TTM figure through Jun 2026 stood at $5.2 billion (down 2.14% YoY), while the FY2025 annual figure was $5.2 billion, up 2.59% from the prior year.
- Receivables came in at $5.2 billion for Q2 2026 at Iqvia Holdings, roughly flat from $5.2 billion in the prior quarter.
- In the past five years, Receivables ranged from a high of $5.5 billion in Q1 2024 to a low of $4.1 billion in Q1 2022.
- Average Receivables over 5 years is $5.0 billion, with a median of $5.2 billion recorded in 2023.
- Year-over-year, Receivables gained 22.92% in 2023 and decreased 5.0% in 2025.
- Over 5 years, Receivables stood at $4.6 billion in 2022, then climbed by 17.04% to $5.4 billion in 2023, then retreated by 4.76% to $5.1 billion in 2024, then gained by 2.59% to $5.2 billion in 2025, then dropped by 1.34% to $5.2 billion in 2026.
- Per Business Quant data, the three most recent Receivables figures were $5.2 billion in Q2 2026, $5.2 billion in Q1 2026, and $5.2 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 5.16 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 463.06 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.51 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 720.47 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 654.40 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 150.69 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 20.41 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 22.87 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 2.06 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 29,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.16 Bn |
| Mar 31, 2026 | 5.16 Bn |
| Dec 31, 2025 | 5.23 Bn |
| Sep 30, 2025 | 5.21 Bn |
| Jun 30, 2025 | 5.28 Bn |
| Mar 31, 2025 | 5.20 Bn |
| Dec 31, 2024 | 5.10 Bn |
| Sep 30, 2024 | 5.30 Bn |
| Jun 30, 2024 | 5.23 Bn |
| Mar 31, 2024 | 5.48 Bn |
| Dec 31, 2023 | 5.36 Bn |
| Sep 30, 2023 | 5.16 Bn |
| Jun 30, 2023 | 5.00 Bn |
| Mar 31, 2023 | 4.84 Bn |
| Dec 31, 2022 | 4.58 Bn |
| Sep 30, 2022 | 4.20 Bn |
| Jun 30, 2022 | 4.15 Bn |
| Mar 31, 2022 | 4.07 Bn |
| Dec 31, 2021 | 3.89 Bn |
| Sep 30, 2021 | 3.58 Bn |